SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6,280 | -37.2% | 2,000 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $10,000 | -16.7% | 2,000 | -33.3% | 0.01% | -14.3% |
Q2 2022 | $12,000 | +33.3% | 3,000 | +100.0% | 0.01% | +75.0% |
Q1 2022 | $9,000 | -18.2% | 1,500 | 0.0% | 0.00% | -20.0% |
Q4 2021 | $11,000 | -21.4% | 1,500 | 0.0% | 0.01% | -44.4% |
Q3 2021 | $14,000 | – | 1,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
Leisure Capital Management | 43,008 | $131,000 | 0.12% |
Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |